Latest & greatest articles for menopause

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on menopause or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on menopause and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for menopause

142. Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis

Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis Hooper L, Ryder JJ, Kurzer MS, Lampe JW, Messina (...) reported. One author had links with a manufacturer of soy/isoflavone products. Authors' conclusions Isoflavone-rich soy products decrease follicle stimulating hormone and luteinizing hormone in premenopausal women and may increase oestradiol in post-menopausal women. Clinical implications of these changes are yet to be determined. CRD commentary The review question was clearly stated and inclusion criteria were appropriately defined. Several relevant sources were searched. Some attempts were made

DARE.2009

143. Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin

Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin Pearce C L, Chung K, Pike M C, Wu A H CRD summary The authors concluded that oestrogen therapy use increased ovarian cancer in a duration-dependent manner; adding progestins (...) appeared to reduce this effect to some extent. The conclusions appeared to be supported by the evidence but the limited search, lack of reporting of review methods and study quality, and reliance upon predominantly observational studies mean that findings should be interpreted with caution. Authors' objectives To examine the relationship between oestrogen-only and oestrogen plus progestin menopausal hormone therapy and the risk of ovarian cancer. Searching PubMed was searched through to December 2007

DARE.2009

144. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis

Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis Toulis K A, Tzellos T, Kouvelas D, Goulis D G CRD summary This review investigated (...) the efficacy and tolerability of gabapentin for the treatment of hot flashes in menopausal women. Gabapentin was associated with reductions in the severity and frequency of hot flashes in menopausal women, but there was substantial variation in the results across the included trials. The authors' conclusions appear to be reliable based on the evidence presented. Authors' objectives To investigate the efficacy and tolerability of gabapentin for the treatment of hot flashes in menopausal women. Searching

DARE.2009

145. Acupuncture for treating menopausal hot flushes: a systematic review

Acupuncture for treating menopausal hot flushes: a systematic review Acupuncture for treating menopausal hot flushes: a systematic review Acupuncture for treating menopausal hot flushes: a systematic review Lee MS, Shin BC, Ernst E CRD summary The review investigated whether acupuncture was effective in reducing the frequency or severity of hot flushes in menopausal women. The authors concluded that there was no convincing evidence that acupuncture is beneficial for these women. The conclusion (...) is likely to be reliable, given the carefully conducted review and relatively high quality of the included studies. Authors' objectives To assess the effectiveness of acupuncture for treating menopausal hot flushes. Searching MEDLINE, AMED, British Nursing Index, CINAHL, EMBASE, PsycINFO, The Cochrane Library, six Korean and four Chinese medical databases . Search terms were reported. The authors' files and the Focus on Alternative and Complementary Therapies journal were searched by hand. No language

DARE.2009

146. A study to establish the feasibility of a trial that would investigate the clinical and cost-effectiveness of stopping bisphosphonate treatment after 5 years in post-menopausal women with osteoporosis who have already had a fracture

A study to establish the feasibility of a trial that would investigate the clinical and cost-effectiveness of stopping bisphosphonate treatment after 5 years in post-menopausal women with osteoporosis who have already had a fracture A study to establish the feasibility of a trial that would investigate the clinical and cost-effectiveness of stopping bisphosphonate treatment after 5 years in post-menopausal women with osteoporosis who have already had a fracture A study to establish (...) the feasibility of a trial that would investigate the clinical and cost-effectiveness of stopping bisphosphonate treatment after 5 years in post-menopausal women with osteoporosis who have already had a fracture Stevenson MD, Oakley JE, Lloyd Jones M, Brennan A, Compston JE, McCloskey EV, Selby PL Citation Stevenson MD, Oakley JE, Lloyd Jones M, Brennan A, Compston JE, McCloskey EV, Selby PL. A study to establish the feasibility of a trial that would investigate the clinical and cost-effectiveness of stopping

Health Technology Assessment (HTA) Database.2009

147. Medical care for menopausal and older women with HIV infection.

Medical care for menopausal and older women with HIV infection. Medical care for menopausal and older women with HIV infection. | National Guideline Clearinghouse Search Sign In Username or Email * Password * Remember Me Don't have an account? Guideline Summary NGC:006480 This guideline summary has been withdrawn from NGC. Please update your bookmarks. View all withdrawn summaries in the . About NGC Guideline Summaries NGC's guidelines summaries contain information systematically derived from

New York State Department of Health2008

148. Herbal supplements did not relieve vasomotor symptoms of menopause in women

Herbal supplements did not relieve vasomotor symptoms of menopause in women Herbal supplements did not relieve vasomotor symptoms of menopause in women | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using (...) your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Herbal supplements did not relieve vasomotor symptoms of menopause in women Article Text Therapeutics Herbal supplements did not relieve vasomotor symptoms of menopause in women Statistics from Altmetric.com No Altmetric data available for this article. Request permissions If you wish to reuse any or all of this article please use the link below which

Evidence-Based Medicine (Requires free registration)2008

149. Menopause.

Menopause. Menopause is the time of life when menstrual cycles cease, and is caused by reduced secretion of the ovarian hormones oestrogen and progesterone. Although menopause is a normal event for women, individual experiences vary, and some women seek medical advice for the management of symptoms. Many symptoms have been attributed to menopause, but only vasomotor dysfunction and vaginal dryness are consistently associated with this time of life in epidemiological studies. Other common (...) symptoms such as mood changes, sleep disturbances, urinary incontinence, cognitive changes, somatic complaints, sexual dysfunction, and reduced quality of life may be secondary to other symptoms, or related to other causes. Trials of therapies for vasomotor dysfunction have shown improvements with oestrogen, gabapentin, paroxetine, and clonidine, but little or no benefit with other agents; adverse effects of these treatments must also be considered. Many questions about menopausal transition and its

Lancet2008

150. Increased risk of parkinsonism in women who underwent oophorectomy before menopause.

Increased risk of parkinsonism in women who underwent oophorectomy before menopause. 17761549 2008 01 15 2008 02 14 2008 01 15 1526-632X 70 3 2008 Jan 15 Neurology Neurology Increased risk of parkinsonism in women who underwent oophorectomy before menopause. 200-9 There is increasing laboratory evidence for a neuroprotective effect of estrogen on the nigrostriatal pathway; however, the epidemiologic evidence remains limited and conflicting. We studied the association of oophorectomy performed (...) before the onset of menopause with the risk of subsequent parkinsonism. We included all women who underwent either unilateral or bilateral oophorectomy before the onset of menopause for a noncancer indication from 1950 through 1987 while residing in Olmsted County, MN. Each member of the oophorectomy cohort was matched by age to a referent woman in the same population who had not undergone oophorectomy. In total, we studied 1,252 women with unilateral oophorectomy, 1,075 women with bilateral

EvidenceUpdates2008

151. Soy isoflavone intake inhibits bone resorption and stimulates bone formation in menopausal women: meta-analysis of randomized controlled trials

Soy isoflavone intake inhibits bone resorption and stimulates bone formation in menopausal women: meta-analysis of randomized controlled trials Soy isoflavone intake inhibits bone resorption and stimulates bone formation in menopausal women: meta-analysis of randomized controlled trials Soy isoflavone intake inhibits bone resorption and stimulates bone formation in menopausal women: meta-analysis of randomized controlled trials Ma D F, Qin, L Q, Wang P Y, Katoh R CRD summary This review (...) and serum bone-specific alkaline phosphatase (BAP) as a marker of bone formation. Included studies used either soy protein containing mainly isoflavones or isoflavone tablets. Isoflavone intake ranged from 37.3 to 118 mg/day and treatment duration from four to 48 weeks. Studies enrolled either Caucasian or Asian women who were not undergoing other osteoporosis therapy, and the majority enrolled post-menopausal women, with mean ages ranging from 51 to 62.4 years. All studies restricted common soy foods

DARE.2008

152. Cost effectiveness of ultrasound and bone densitometry for osteoporosis screening in post-menopausal women

Cost effectiveness of ultrasound and bone densitometry for osteoporosis screening in post-menopausal women Cost effectiveness of ultrasound and bone densitometry for osteoporosis screening in post-menopausal women Cost effectiveness of ultrasound and bone densitometry for osteoporosis screening in post-menopausal women Mueller D, Gandjour A Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of ultrasound and bone densitometry for osteoporosis screening in post-menopausal women. Applied Health Economics and Health Policy 2008; 6(2-3): 113-135 PubMedID DOI Original Paper URL Indexing Status Subject indexing assigned by NLM MeSH Absorptiometry, Photon /economics; Aged; Aged, 80 and over; Alendronate /economics /therapeutic use; Bone Density; Bone Density Conservation Agents /economics /therapeutic use; Bone and Bones /ultrasonography; Cost-Benefit Analysis; Female; Fractures, Bone /economics

NHS Economic Evaluation Database.2008

154. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy

Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy Borrelli F, Ernst E CRD summary The evidence did not consistently demonstrate an effect of black cohosh on menopausal symptoms; a beneficial effect on perimenopausal women could not be excluded. The findings (...) of this review should be considered with caution bearing in mind potential methodological weaknesses of the review processes and synthesis. Authors' objectives To review the efficacy of black cohosh Cimicifuga racemosa for treating menopausal symptoms. Searching A number of databases were searched from inception to December 2007, including MEDLINE, EMBASE, AMED, Phytobase and The Cochrane Library without language restrictions. Manufacturers of relevant products were contacted and bibliographies of included

DARE.2008

155. Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials

Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials Ma D F, Qin L Q, Wang P Y, Katoh R CRD summary The authors concluded that isoflavones significantly (...) reduced spine bone loss in menopausal women; effects were greater when more than 90mg/day of isoflavones was consumed and isoflavone was taken for six months. The evidence appears to support the authors’ conclusions, but the non significant results at 12 months were unexplained and may weaken the strength of evidence supporting the reported benefits of isoflavones. Authors' objectives To evaluate the effect of isoflavones on spinal bone mass in women. Searching MEDLINE (from 1966), EMBASE (from 1985

DARE.2008

156. Review: sparse good quality evidence supports the use of alternative therapies for menopausal symptoms

Review: sparse good quality evidence supports the use of alternative therapies for menopausal symptoms Review: sparse good quality evidence supports the use of alternative therapies for menopausal symptoms | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name (...) or password? Search for this keyword Search for this keyword Main menu Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: sparse good quality evidence supports the use of alternative therapies for menopausal symptoms Article Text Treatment Review: sparse good quality evidence supports the use of alternative therapies for menopausal symptoms Statistics from

Evidence-Based Nursing (Requires free registration)2008

157. Combined HRT increased CV events more than placebo but did not differ from oestrogen HRT after menopause

Combined HRT increased CV events more than placebo but did not differ from oestrogen HRT after menopause Combined HRT increased CV events more than placebo but did not differ from oestrogen HRT after menopause | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Combined HRT increased CV events more than placebo but did not differ from oestrogen HRT after menopause Article Text Therapeutics Combined HRT increased CV events more than placebo but did not differ from oestrogen HRT after menopause Statistics from Altmetric.com No Altmetric data available

Evidence-Based Medicine (Requires free registration)2008

158. Exercise for vasomotor menopausal symptoms.

Exercise for vasomotor menopausal symptoms. BACKGROUND: Evidence suggests that a high proportion of perimenopausal and early postmenopausal women will experience some menopause symptoms, hot flushes being the most common. The effects caused by falling levels of estrogen may be alleviated by hormone replacement therapy (HRT) but there has been a marked global decline in the prescription and use of HRT due to concerns about the risks and benefits of HRT; consequently many women are now seeking (...) alternatives. As large numbers of women are choosing not to take HRT, it is increasingly important to identify evidence based lifestyle modifications, which can have a positive effect on menopausal symptoms. OBJECTIVES: To examine the effectiveness of any type of exercise intervention in the management of vasomotor menopausal symptoms (hot flushes and night sweats) in perimenopausal and postmenopausal women. SEARCH STRATEGY: Searches of the following electronic bibliographic databases were performed

Cochrane2007

159. Effect of weighted exercises on bone mineral density in post menopausal women: a systematic review

Effect of weighted exercises on bone mineral density in post menopausal women: a systematic review Effect of weighted exercises on bone mineral density in post menopausal women: a systematic review Effect of weighted exercises on bone mineral density in post menopausal women: a systematic review Zehnacker C H, Bemis-Dougherty A CRD summary The review concluded that weighted exercises can be beneficial in maintaining bone mineral density (BMD) in postmenopausal women, and in increasing BMD of (...) on bone mineral density in post menopausal women: a systematic review. Journal of Geriatric Physical Therapy 2007; 30(2): 79-88 PubMedID Original Paper URL Indexing Status Subject indexing assigned by NLM MeSH Aging /physiology; Bone Density; Exercise /physiology; Female; Humans; Osteoporosis, Postmenopausal /physiopathology /prevention & Postmenopause; control AccessionNumber 12007003006 Date bibliographic record published 14/02/2008 Date abstract record published 30/09/2008 Record Status

DARE.2007

160. Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta-analysis

Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta-analysis Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta-analysis Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta-analysis Thompson Coon J, Pittler M H, Ernst E CRD summary The authors concluded that Trifolium pratense isoflavones appear effective in treating hot flushes (...) , but the clinical relevance of the effect is unclear, adverse events related to short-term use were not apparent and long-term use requires further research. The conclusions were drawn from a few studies involving few participants and showing conflicting evidence, and may not be reliable. Authors' objectives To evaluate the effects of Trifolium pratense isoflavone supplements on the frequency of hot flushes in menopausal women. Searching MEDLINE (from 1951), EMBASE (from 1974), CINAHL (from 1982), AMED (from

DARE.2007